Up­dat­ed: Ot­su­ka buys out small mol­e­cule drug dis­cov­ery start­up Jnana and its rare dis­ease pill for $800M cash

Ot­su­ka Phar­ma­ceu­ti­cal is pay­ing at least $800 mil­lion to ac­quire Jnana Ther­a­peu­tics, a Roche-part­nered small mol­e­cule drug dis­cov­ery out­fit ready to put its first can­di­date …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER